[90A2-90A2];[90D1-90D1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
90A2;90D1
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3R)ED5780.
The presence of P+PBac{XP5.WH5}BSC565 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc.
determined the insertion site of the progenitor insertion PBac{WH}beat-IIaf00670 to be at Release 3 genomic coordinate 13181235 on chromosome arm 3R. This corresponds to 90A2 on the Release 3 and Release 5 genome maps. The predicted position of the progenitor insertion P{XP}cpod05694 on the Release 5 map is 90D1. Consequently, the cytological breakpoints of Df(3R)BSC565 are predicted to be 90A2;90D1.